A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Clinical trial NCT07260669 · RECRUITING
Trial details
- NCT number
- NCT07260669
- Sponsor
- Gesynta Pharma AB
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2027-06-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.